![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » GenMark Achieves Updated CE Mark for its ePlex Blood Culture Identification Fungal Pathogen Panel
GenMark Achieves Updated CE Mark for its ePlex Blood Culture Identification Fungal Pathogen Panel
![](https://www.fdanews.com/ext/resources/test/Drug-Images/brownlightedtesttubes.jpg?t=1446155605&width=430)
California–based Genmark have secured a CE mark or its ePlex blood culture identification fungal pathogen panel.
The device CE mark will include BCID gram-positive and gram-negative panels.
The ePlex systems are designed to support a broad range of molecular diagnostic tests with a compact, simple workstation and self-contained, disposable test cartridges. — Cynthia Jessup
Upcoming Events
-
21Oct